Evaluating the Effect of Bathing Additives in Atopic Dermatitis

Clinical Trial ID: NCT04001855


This proposed project will be an open-label, split-arm, randomized controlled pilot study. Up to 60 patients diagnosed with atopic dermatitis (eczema) will be enrolled in the study. The purpose of this study is to understand the change in skin barrier function and skin microbial composition in patients with atopic dermatitis following dilute bleach bath/soak and dilute vinegar bath/soak.

Atopic dermatitis (AD), also known as eczema, is an inflammatory skin condition that affects children and adults and causes skin redness, dryness and itching. Dilute bleach baths are standard of care for treatment of AD and work to decrease skin inflammation and modulate the skin microbiome. Dilute vinegar (acetic acid) has been reported to have similar effects on the skin. The purpose of this study is to evaluate the change in skin barrier function and skin microbial composition following baths or gauze soaks with dilute bleach and dilute vinegar.


Inclusion Criteria: - Males and females, at least 5 years of age - Subjects, parents/legal guardians must be able to comprehend and read the English language - Subjects must have a diagnosis of atopic dermatitis (AD) by a board-certified dermatologist Exclusion Criteria: - Subjects who do not fit the inclusion criteria - Subjects unable or unwilling to comply with the study procedures - Concurrently have other inflammatory skin conditions - Prior known allergies to any components of the materials used - A subject who in the opinion of the investigator will be uncooperative or unable to comply with study procedures - Subject unable to speak or read the English language - Those that are pregnant, prisoners or cognitively impaired

  • Start Date


  • Last Updated


  • Sponsor

    University of Arizona

  • Condition Name

    Atopic Dermatitis

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.